Technology
Health
Medical

Zimmer Biomet

$127.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.71 (1.36%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Zimmer Biomet and other stocks, options, ETFs, and crypto commission-free!

About

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Read More Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Employees
19,000
Headquarters
Warsaw, Indiana
Founded
1927
Market Cap
26.00B
Price-Earnings Ratio
Dividend Yield
0.93
Average Volume
1.19M
High Today
$128.47
Low Today
$125.56
Open Price
$125.56
Volume
989.09K
52 Week High
$134.55
52 Week Low
$96.99

Collections

Technology
Health
Medical
Healthcare
Sports
Entertainment
US
North America

News

TradingNewsNowMar 19

Stock in the Spotlight: Zimmer Biomet (NYSE: ZBH)

Zimmer Biomet trades as part of the medical devices industry and trades as part of the healthcare sector. The company CEO is Bryan C. Hanson. Zimmer Biomet Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, Persona, Zimmer, and Polaris. Previous Intraday Trading Performance: The ZBH stock showed a previous change of -0.48% with an open at 126.41 and a close of...

11
Yahoo FinanceMar 18

Zimmer Biomet Solid on Global Prospects Despite Price Pressure

On Mar 15, we issued an updated research report on Zimmer Biomet Holdings, Inc. ZBH.The company continues to witness strength in the Asia Pacific (APAC) and Europe, Middle East and Africa (EMEA) regions. However, pricing continues to remain a major concern for this Zacks Rank #3 (Hold) company. This leading musculoskeletal healthcare company has been outperforming its industry over the past three months. The stock has gained 20.4% in comparison with the industry’s 13.6% rise. Over the recent past, Zimmer ...

5
Guru FocusMar 12

Zimmer Biomet Exhibits Unique Ecosystem of Solutions at AAOS 2019

WARSAW, Ind., March 12, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it will be showcasing its latest commercial offerings and previewing its next generation of technological innovations at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, March 13-15 in Las Vegas, Nevada. "In addition to our ongoing commitment to advancing our traditional implant offering, Zimmer Biomet is transforming the patient jo...

30

Earnings

$1.61
$1.80
$1.99
$2.18
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 25, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.